Medical trial workflow platform OneStudyTeam, a Reify Well being firm, has laid off 160 workers, or roughly 25% of its workforce.
“We will affirm that we made the very tough resolution to let a few of our workforce members go. Every particular person performed a task in constructing OneStudyTeam, and we’re grateful for his or her contribution to our mission of accelerating the event of lifesaving therapies for sufferers. We concluded that we have to restructure our workforce going into 2023 to streamline operations after a interval of extraordinarily fast progress and hiring,” an organization spokesperson instructed MobiHealthNews in an e-mail.
THE LARGER TREND
In November, OneStudyTeam announced a partnership with New York-based Antidote Technologies to supply one platform for scientific trial sponsors, websites and members. The platform would make the most of OneStudyTeam’s cloud-based software program generally known as StudyTeam, in addition to Antidote’s patient-engagement platform.
In April, OneStudyTeam’s father or mother firm Reify garnered $220 million in Series D funding, boosting the corporate’s valuation to $4.8 billion.